We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$3.85B
AUM Growth
-$284M
Cap. Flow
-$132M
Cap. Flow %
-3.43%
Top 10 Hldgs %
21.54%
Holding
5,768
New
656
Increased
2,740
Reduced
1,651
Closed
687

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Financials 7.64%
3 Healthcare 7.18%
4 Consumer Discretionary 6.43%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRWG icon
4501
GrowGeneration
GRWG
$87.1M
$2.3K ﹤0.01%
+2,089
New +$2.6K
AMIX
4502
Autonomix Medical
AMIX
$1.95M
$2.28K ﹤0.01%
278
-1
-0.4% -$9
ALBT
4503
DELISTED
Avalon GloboCare
ALBT
$2.28K ﹤0.01%
4,286
+3,374
+370% +$2.8K
CLRO icon
4504
ClearOne Inc
CLRO
$11.5M
$2.27K ﹤0.01%
639
-76
-11% -$416
OBAI
4505
Our Bond Inc
OBAI
$12.5M
$2.27K ﹤0.01%
+1,556
New +$6.88K
ILAG icon
4506
Intelligent Living
ILAG
$6.92M
$2.27K ﹤0.01%
+1,000
New +$2.99K
TSLQ icon
4507
Tradr TSLA Bear Daily ETF
TSLQ
$145M
$2.26K ﹤0.01%
+92
New +$1.93K
ONFO icon
4508
Onfolio Holdings
ONFO
$593K
$2.26K ﹤0.01%
3,246
-5
-0.2% -$3
KYNB
4509
Kyntra Bio
KYNB
$27.5M
$2.25K ﹤0.01%
332
+116
+54% +$908
IXJ icon
4510
iShares Global Healthcare ETF
IXJ
$4.11B
$2.25K ﹤0.01%
+24
New +$2.35K
ASBP
4511
Aspire Biopharma
ASBP
$8.7M
$2.24K ﹤0.01%
72
+64
+800% +$3.41K
GCTK icon
4512
GlucoTrack
GCTK
$5.12M
$2.24K ﹤0.01%
3,442
+3,017
+710% +$6.41K
IBDS icon
4513
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
$2.23K ﹤0.01%
92
-968
-91% -$23.5K
AXG
4514
Solowin Holdings
AXG
$579M
$2.23K ﹤0.01%
+632
New +$2.39K
TWIN icon
4515
Twin Disc
TWIN
$329M
$2.21K ﹤0.01%
+147
New +$2.48K
KAPA
4516
Kairos Pharma
KAPA
$6.42M
$2.21K ﹤0.01%
3,962
-265
-6% -$178
RRGB icon
4517
Red Robin
RRGB
$144M
$2.21K ﹤0.01%
755
+141
+23% +$529
SCHD icon
4518
Schwab US Dividend Equity ETF
SCHD
$103B
$2.21K ﹤0.01%
72
+20
+38% +$607
DKI
4519
DarkIris Inc
DKI
$9.02M
$2.2K ﹤0.01%
+469
New +$3.19K
IXN icon
4520
iShares Global Tech ETF
IXN
$8.34B
$2.2K ﹤0.01%
22
-31
-58% -$3.27K
XLB icon
4521
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$2.2K ﹤0.01%
44
-109,619
-100% -$5.5M
NVOX
4522
Defiance Daily Target 2x Long NVO ETF
NVOX
$46.8M
$2.2K ﹤0.01%
215
+118
+122% +$2.18K
WLYB icon
4523
John Wiley & Sons Class B
WLYB
$2.69B
$2.2K ﹤0.01%
+57
New +$1.87K
CLNN icon
4524
Clene
CLNN
$64.4M
$2.19K ﹤0.01%
+444
New +$2.27K
TOMZ icon
4525
TOMI Environmental Solutions
TOMZ
$12.3M
$2.17K ﹤0.01%
1,311
-94
-7% -$198

Similar funds

Tower Research Capital (TRC)'s Q1 2026 Portfolio in Review

As of Q1 2026, Tower Research Capital (TRC) held 5,768 positions worth $3.85B, down 6.9% from $4.13B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC) withdrew a net $132M in Q1 2026, closing 687 positions and reducing 1,651 holdings. Its most notable exit was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $58.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core US Aggregate Bond ETF worth $39.7M.

  • Tower Research Capital (TRC)'s largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 400,371 shares worth $39.7M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2026, an estimated $147M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2026 reduction was NVIDIA, cutting an estimated $104M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q1 2026, selling an estimated $58.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.85B portfolio in Q1 2026.
  • Tower Research Capital (TRC) opened 656 new positions and closed 687 in Q1 2026.
  • Tower Research Capital (TRC)'s portfolio value fell 6.9% quarter-over-quarter to $3.85B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.